Atom Investors LP Invitae Corp Transaction History

Atom Investors LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.28 - $15.59 $178,364 - $442,787	-28,402 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $417,509 - $814,285	28,402 New	28,402 $434,000
Q4 2020 Feb 16, 2021	SELL	$39.09 - $57.4 $983,543 - $1.44 Million	-25,161 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$28.43 - $44.67 $715,327 - $1.12 Million	25,161 New	25,161 $1.09 Million
Q1 2020 May 15, 2020	SELL	$7.64 - $27.5 $5.11 Million - $18.4 Million	-669,163 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$15.02 - $20.57 $3.47 Million - $4.75 Million	230,977 Added 52.71%	669,163 $10.8 Million
Q3 2019 Nov 14, 2019	BUY	$18.85 - $27.5 $7.51 Million - $11 Million	398,189 Added 995.55%	438,186 $8.44 Million
Q2 2019 Aug 14, 2019	SELL	$17.37 - $26.27 $867,405 - $1.31 Million	-49,937 Reduced 55.53%	39,997 $940,000
Q1 2019 May 15, 2019	BUY	$10.65 - $25.75 $957,797 - $2.32 Million	89,934 New	89,934 $2.11 Million

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.